developsTreatmentFor

P69333
predicate

Indicates that one entity creates or advances a medical or therapeutic intervention intended to address a condition, disease, or problem affecting another entity.

All labels observed (4)

Label Occurrences
developsTreatmentFor canonical 27
developedForTreatmentOf 1
treatmentDevelopedClass 1

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: developsTreatmentFor
Generated description
Indicates that one entity creates or advances a medical or therapeutic intervention intended to address a condition, disease, or problem affecting another entity.

Sample triples (30)

Subject Object
Regeneron Pharmaceuticals age-related macular degeneration ⓘ
Regeneron Pharmaceuticals diabetic macular edema ⓘ
Regeneron Pharmaceuticals atopic dermatitis ⓘ
Regeneron Pharmaceuticals asthma ⓘ
Regeneron Pharmaceuticals cancer ⓘ
Regeneron Pharmaceuticals inflammatory diseases ⓘ
Regeneron Pharmaceuticals COVID-19 ⓘ
Ridgeback Biotherapeutics Ebola virus disease ⓘ
Ridgeback Biotherapeutics COVID-19 ⓘ
linked to: COVID-19 pandemic
Ridgeback Biotherapeutics serious infectious diseases ⓘ
Alexion Pharmaceuticals paroxysmal nocturnal hemoglobinuria ⓘ
Alexion Pharmaceuticals atypical hemolytic uremic syndrome ⓘ
Alexion Pharmaceuticals generalized myasthenia gravis ⓘ
Alexion Pharmaceuticals neuromyelitis optica spectrum disorder ⓘ
Alexion Pharmaceuticals hypophosphatasia ⓘ
Alexion Pharmaceuticals lysosomal acid lipase deficiency ⓘ
Genzyme Gaucher disease ⓘ
Genzyme Fabry disease ⓘ
Genzyme Pompe disease ⓘ
Genzyme multiple sclerosis ⓘ
Genzyme chronic kidney disease ⓘ
BioMarin Pharmaceutical mucopolysaccharidosis I ⓘ
BioMarin Pharmaceutical mucopolysaccharidosis VI ⓘ
BioMarin Pharmaceutical mucopolysaccharidosis IVA ⓘ
BioMarin Pharmaceutical phenylketonuria ⓘ
BioMarin Pharmaceutical CLN2 disease ⓘ
BioMarin Pharmaceutical achondroplasia ⓘ
Augusto Odone adrenoleukodystrophy via predicate surface "developedForTreatmentOf" ⓘ
Augusto Odone mixture of oleic acid and erucic acid via predicate surface "treatmentDevelopedIs" ⓘ
Augusto Odone dietary therapy via predicate surface "treatmentDevelopedClass" ⓘ